Israel Active

Medical researchers at Hadassah Medical School in Jerusalem studying the effects of liver transplants in mice, found that in 96% of older, pregnant rodents, the liver regenerated within two days. This compared with 82% of young, non-pregnant mice and 46% of older, non-pregnant ones.

Israel’s Timocco makes motor skills games for developmentally disabled and autistic children. It is now locating its US HQ in Akron Ohio and is working with Akron Children's Hospital, Cleveland Clinic and University Hospitals to introduce the software.

Israel’s Ninox Medical has raised $10 million to fund its development of a new device for the treatment of Obstructive Sleep Apnea (OSA). It is designed to be effective, comfortable to use, and without the side effects typical of other treatment devices.   

Motivation, physiotherapy from Sheba medical center and use of a Wii console were key to Captain Shir Klevner’s speedy return to his unit, where he completed intensive training only 8 months after his leg was shattered by a sniper’s bullet in Gaza.

Scientists working in the Technion laboratory of Israeli Nobel Prize winner Professor Aaron Ciechanover have discovered that high concentrations of the chemical KPC1 and protein p50 suppress malignant growth and protect healthy cells.

Scientists at Israel’s Weizmann Institute have identified that cancer can be triggered by an overload of specific messages from the cell membrane to its nucleus. They have also found a molecule that can filter these messages, similar to the way spam emails are blocked.

Researchers at Israel’s Technion and Haifa’s Rambam hospital have discovered that combining pomegranate juice and dates (with their pits) provides maximum protection against the buildup of plaque on the endothelium of the arteries, and prevents heart attack or stroke.   

Scientists at Israel’s Weizmann Institute working with Australian scientists have used the hormone neuregulin to re-grow heart tissue damaged by a heart attack or heart disease. See this rare positive report in the normally anti-Israel UK Guardian. Also published in Nature Cell Biology.   

FDA approval has been given to the iPhone / iPad app TraumaCad by Israeli health-tech firm Voyant, which helps doctors plan hip replacement on mobile devices. It allows doctors to import digital implant images from secure hospital networks and visualize the operation.

Israel’s Teva has received FDA approval for ProAir RespiClick - the first and only breath-actuated, dry-powder rescue inhaler to be approved by the FDA for the treatment of acute asthma symptoms. ProAir RespiClick eliminates the need for hand-breath coordination during inhalation.